{"transactions":[{"id":931020,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":39000,"derivative":{"underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931019,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":21000,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931018,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":52900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":52900,"derivative":{"underlying":"Common Stock","underlying_shares":52900},"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931017,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":184600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":184600,"derivative":{"exercise_price":36.76,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":184600},"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931016,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":5654,"price":36.82,"value":208180.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":7346,"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931015,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931014,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":4785,"price":36.82,"value":176183.7,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":5715,"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":931013,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2026-01-26T16:43:34.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001615993-26-000002","document":"form4-01262026_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599326000002/form4-01262026_090130.xml","form_type":"4"}},{"id":964351,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2025-12-17T17:25:05.000Z","date":"2025-12-12","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five equal annual installments beginning on November 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001615993-25-000005","document":"form4-12172025_051201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599325000005/form4-12172025_051201.xml","form_type":"4"}},{"id":964350,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2025-12-17T17:25:05.000Z","date":"2025-12-12","kind":"sale","planned":true,"acquired":false,"shares":5933,"price":40.1073,"value":237956.6109,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.28. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001615993-25-000005","document":"form4-12172025_051201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599325000005/form4-12172025_051201.xml","form_type":"4"}},{"id":964349,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2025-12-17T17:25:05.000Z","date":"2025-12-12","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":40.1073,"value":802146.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.28. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001615993-25-000005","document":"form4-12172025_051201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599325000005/form4-12172025_051201.xml","form_type":"4"}},{"id":964348,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2025-12-17T17:25:05.000Z","date":"2025-12-12","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":8.22,"value":164400.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001615993-25-000005","document":"form4-12172025_051201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000161599325000005/form4-12172025_051201.xml","form_type":"4"}},{"id":1292806,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Restricted Stock Units","published_at":"2025-01-28T16:07:41.000Z","date":"2025-01-25","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":52000,"derivative":{"underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001415889-25-002159","document":"form4-01282025_090137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588925002159/form4-01282025_090137.xml","form_type":"4"}},{"id":1292805,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2025-01-28T16:07:41.000Z","date":"2025-01-25","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests with respect to 25% of the underlying shares on January 25, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":180000,"derivative":{"exercise_price":38.01,"expiration_date":"2035-01-25","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001415889-25-002159","document":"form4-01282025_090137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588925002159/form4-01282025_090137.xml","form_type":"4"}},{"id":1292804,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Restricted Stock Units","published_at":"2025-01-28T16:07:41.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":31500,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001415889-25-002159","document":"form4-01282025_090137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588925002159/form4-01282025_090137.xml","form_type":"4"}},{"id":1292803,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2025-01-28T16:07:41.000Z","date":"2025-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":4567,"price":38.01,"value":173591.67,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":5933,"source":{"system":"sec-edgar","filing":"0001415889-25-002159","document":"form4-01282025_090137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588925002159/form4-01282025_090137.xml","form_type":"4"}},{"id":1292802,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2025-01-28T16:07:41.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001415889-25-002159","document":"form4-01282025_090137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588925002159/form4-01282025_090137.xml","form_type":"4"}},{"id":1296166,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2025-01-23T16:17:43.000Z","date":"2025-01-21","kind":"exercise","planned":true,"acquired":false,"shares":9737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests in five equal annual installments beginning on March 1, 2021."}],"balance_after":2435,"derivative":{"exercise_price":8.22,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":9737},"source":{"system":"sec-edgar","filing":"0001415889-25-001931","document":"form4-01232025_090139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588925001931/form4-01232025_090139.xml","form_type":"4"}},{"id":1296165,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2025-01-23T16:17:43.000Z","date":"2025-01-21","kind":"exercise","planned":true,"acquired":false,"shares":6086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in five equal annual installments beginning on January 1, 2020."}],"balance_after":0,"derivative":{"exercise_price":8.22,"expiration_date":"2029-01-07","underlying":"Common Stock","underlying_shares":6086},"source":{"system":"sec-edgar","filing":"0001415889-25-001931","document":"form4-01232025_090139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588925001931/form4-01232025_090139.xml","form_type":"4"}},{"id":1296164,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2025-01-23T16:17:43.000Z","date":"2025-01-21","kind":"exercise","planned":true,"acquired":false,"shares":3470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five equal annual installments beginning on November 1, 2018."}],"balance_after":20000,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":3470},"source":{"system":"sec-edgar","filing":"0001415889-25-001931","document":"form4-01232025_090139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588925001931/form4-01232025_090139.xml","form_type":"4"}},{"id":1296163,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2025-01-23T16:17:43.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":19293,"price":40.1309,"value":774245.4537,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.50. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-001931","document":"form4-01232025_090139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588925001931/form4-01232025_090139.xml","form_type":"4"}},{"id":1296162,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Common Stock","published_at":"2025-01-23T16:17:43.000Z","date":"2025-01-21","kind":"exercise","planned":true,"acquired":true,"shares":19293,"price":8.22,"value":158588.46,"ownership":{"direct":true},"balance_after":19293,"source":{"system":"sec-edgar","filing":"0001415889-25-001931","document":"form4-01232025_090139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588925001931/form4-01232025_090139.xml","form_type":"4"}},{"id":1669239,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Restricted Stock Units","published_at":"2024-01-26T16:56:25.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":42000,"derivative":{"underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001415889-24-001872","document":"form4-01262024_090119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588924001872/form4-01262024_090119.xml","form_type":"4"}},{"id":1669238,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2024-01-26T16:56:25.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":202250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":202250,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":202250},"source":{"system":"sec-edgar","filing":"0001415889-24-001872","document":"form4-01262024_090119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588924001872/form4-01262024_090119.xml","form_type":"4"}},{"id":1873103,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2023-05-31T16:37:09.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4/A is being filed to amend the exercise price of the granted options previously reported as being $35.99 to $35.56."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests with respect to 50% of the underlying shares on May 25, 2025, with the remaining shares vesting in twenty-four equal monthly installments beginning on June 25, 2025."}],"balance_after":125000,"derivative":{"exercise_price":35.56,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-23-008971","document":"form4a-05312023_080505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588923008971/form4a-05312023_080505.xml","form_type":"4/A","original_submission_date":"2023-05-30"}},{"id":1874229,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"Stock Option","published_at":"2023-05-30T16:26:21.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests with respect to 50% of the underlying shares on May 25, 2025, with the remaining shares vesting in twenty-four equal monthly installments beginning on June 25, 2025."}],"balance_after":125000,"derivative":{"exercise_price":35.99,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-23-008914","document":"form4-05302023_080517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588923008914/form4-05302023_080517.xml","form_type":"4"}},{"id":2124153,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2022-11-04T16:05:21.000Z","date":"2022-11-03","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five equal annual installments beginning on November 1, 2018."}],"balance_after":23470,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-22-011083","document":"form4-11042022_041101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588922011083/form4-11042022_041101.xml","form_type":"4"}},{"id":2124152,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-11-04T16:05:21.000Z","date":"2022-11-03","kind":"sale","acquired":false,"shares":15000,"price":60.0221,"value":900331.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.23. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-011083","document":"form4-11042022_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588922011083/form4-11042022_041101.xml","form_type":"4"}},{"id":2124151,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-11-04T16:05:21.000Z","date":"2022-11-03","kind":"exercise","acquired":true,"shares":15000,"price":8.22,"value":123300.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001415889-22-011083","document":"form4-11042022_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588922011083/form4-11042022_041101.xml","form_type":"4"}},{"id":2126831,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option","published_at":"2022-11-02T16:04:32.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in five equal annual installments beginning on November 1, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Form 4 filed by the reporting person on October 20, 2021, understated the number of securities owned following the reported transaction by 1 share. The amount of securities reported herein reflects the correct number of securities owned following the transactions reported on this Form 4."}],"balance_after":38470,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-22-010986","document":"form4-11022022_011117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588922010986/form4-11022022_011117.xml","form_type":"4"}},{"id":2126830,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-11-02T16:04:32.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":15000,"price":55.1039,"value":826558.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.62. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-010986","document":"form4-11022022_011117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588922010986/form4-11022022_011117.xml","form_type":"4"}},{"id":2126829,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-11-02T16:04:32.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":15000,"price":8.22,"value":123300.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001415889-22-010986","document":"form4-11022022_011117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000141588922010986/form4-11022022_011117.xml","form_type":"4"}},{"id":2537939,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-10-20T21:07:55.000Z","date":"2021-10-19","kind":"exercise","acquired":false,"shares":4101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is currently vested with respect to 62,082 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on November 1, 2021."}],"balance_after":53469,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":4101},"source":{"system":"sec-edgar","filing":"0001104659-21-128203","document":"tm2129561-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000110465921128203/tm2129561-2_4seq1.xml","form_type":"4"}},{"id":2537938,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-10-20T21:07:55.000Z","date":"2021-10-19","kind":"exercise","acquired":false,"shares":14099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is currently vested with respect to 62,082 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on November 1, 2021."}],"balance_after":57570,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":14099},"source":{"system":"sec-edgar","filing":"0001104659-21-128203","document":"tm2129561-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000110465921128203/tm2129561-2_4seq1.xml","form_type":"4"}},{"id":2537937,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-20T21:07:55.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":4101,"price":43.7714,"value":179506.5114,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.70 to $43.99. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-128203","document":"tm2129561-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000110465921128203/tm2129561-2_4seq1.xml","form_type":"4"}},{"id":2537936,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-20T21:07:55.000Z","date":"2021-10-19","kind":"exercise","acquired":true,"shares":4101,"price":8.22,"value":33710.22,"ownership":{"direct":true},"balance_after":4101,"source":{"system":"sec-edgar","filing":"0001104659-21-128203","document":"tm2129561-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000110465921128203/tm2129561-2_4seq1.xml","form_type":"4"}},{"id":2537935,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-20T21:07:55.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":14099,"price":43.1262,"value":608036.2938,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.65 to $43.63. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-128203","document":"tm2129561-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000110465921128203/tm2129561-2_4seq1.xml","form_type":"4"}},{"id":2537934,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-20T21:07:55.000Z","date":"2021-10-19","kind":"exercise","acquired":true,"shares":14099,"price":8.22,"value":115893.78,"ownership":{"direct":true},"balance_after":14099,"source":{"system":"sec-edgar","filing":"0001104659-21-128203","document":"tm2129561-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000110465921128203/tm2129561-2_4seq1.xml","form_type":"4"}},{"id":2546093,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-10-07T18:55:40.000Z","date":"2021-10-06","kind":"exercise","acquired":false,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is currently vested with respect to 62,082 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on November 1, 2021."}],"balance_after":71669,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":1800},"source":{"system":"sec-edgar","filing":"0001104659-21-124273","document":"tm2129561-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000110465921124273/tm2129561-1_4seq1.xml","form_type":"4"}},{"id":2546092,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-07T18:55:40.000Z","date":"2021-10-06","kind":"sale","acquired":false,"shares":1800,"price":40.0992,"value":72178.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.075 to $40.41. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-124273","document":"tm2129561-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000110465921124273/tm2129561-1_4seq1.xml","form_type":"4"}},{"id":2546091,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-07T18:55:40.000Z","date":"2021-10-06","kind":"exercise","acquired":true,"shares":1800,"price":8.22,"value":14796.0,"ownership":{"direct":true},"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001104659-21-124273","document":"tm2129561-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000110465921124273/tm2129561-1_4seq1.xml","form_type":"4"}},{"id":2574359,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-09-09T21:23:50.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is currently vested with respect to 62,082 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on November 1, 2021."}],"balance_after":73469,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-035505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321035505/doc4.xml","form_type":"4"}},{"id":2574358,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-09T21:23:50.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":10000,"price":37.5783,"value":375783.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.78. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-035505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321035505/doc4.xml","form_type":"4"}},{"id":2574357,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-09T21:23:50.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":10000,"price":8.22,"value":82200.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-21-035505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321035505/doc4.xml","form_type":"4"}},{"id":2586214,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-08-30T16:31:17.000Z","date":"2021-08-27","kind":"exercise","acquired":false,"shares":7841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is currently vested with respect to 82,777 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 13, 2021."}],"balance_after":83469,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":7841},"source":{"system":"sec-edgar","filing":"0000899243-21-034517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321034517/doc4.xml","form_type":"4"}},{"id":2586213,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-08-30T16:31:17.000Z","date":"2021-08-26","kind":"exercise","acquired":false,"shares":2159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is currently vested with respect to 82,777 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 13, 2021."}],"balance_after":91310,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":2159},"source":{"system":"sec-edgar","filing":"0000899243-21-034517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321034517/doc4.xml","form_type":"4"}},{"id":2586212,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-30T16:31:17.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":7841,"price":35.1614,"value":275700.5374,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.43. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-034517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321034517/doc4.xml","form_type":"4"}},{"id":2586211,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-30T16:31:17.000Z","date":"2021-08-27","kind":"exercise","acquired":true,"shares":7841,"price":8.22,"value":64453.02,"ownership":{"direct":true},"balance_after":7841,"source":{"system":"sec-edgar","filing":"0000899243-21-034517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321034517/doc4.xml","form_type":"4"}},{"id":2586210,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-30T16:31:17.000Z","date":"2021-08-26","kind":"sale","acquired":false,"shares":2159,"price":35.0075,"value":75581.1925,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.09. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-034517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321034517/doc4.xml","form_type":"4"}},{"id":2586209,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-30T16:31:17.000Z","date":"2021-08-26","kind":"exercise","acquired":true,"shares":2159,"price":8.22,"value":17746.98,"ownership":{"direct":true},"balance_after":2159,"source":{"system":"sec-edgar","filing":"0000899243-21-034517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321034517/doc4.xml","form_type":"4"}},{"id":2606432,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-08-11T16:30:36.000Z","date":"2021-08-10","kind":"exercise","acquired":false,"shares":9950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is currently vested with respect to 82,777 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 13, 2021."}],"balance_after":93469,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":9950},"source":{"system":"sec-edgar","filing":"0000899243-21-032526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321032526/doc4.xml","form_type":"4"}},{"id":2606431,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-11T16:30:36.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":9950,"price":30.2145,"value":300634.275,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.75. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-032526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321032526/doc4.xml","form_type":"4"}},{"id":2606430,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-11T16:30:36.000Z","date":"2021-08-10","kind":"exercise","acquired":true,"shares":9950,"price":8.22,"value":81789.0,"ownership":{"direct":true},"balance_after":9950,"source":{"system":"sec-edgar","filing":"0000899243-21-032526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321032526/doc4.xml","form_type":"4"}},{"id":2625652,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-07-23T16:30:57.000Z","date":"2021-07-22","kind":"exercise","acquired":false,"shares":50,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is currently vested with respect to 82,777 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 13, 2021."}],"balance_after":103419,"derivative":{"exercise_price":8.22,"expiration_date":"2027-11-13","underlying":"Common Stock","underlying_shares":50},"source":{"system":"sec-edgar","filing":"0000899243-21-029687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321029687/doc4.xml","form_type":"4"}},{"id":2625651,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-23T16:30:57.000Z","date":"2021-07-22","kind":"sale","acquired":false,"shares":50,"price":30,"value":1500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-029687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321029687/doc4.xml","form_type":"4"}},{"id":2625650,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-23T16:30:57.000Z","date":"2021-07-22","kind":"exercise","acquired":true,"shares":50,"price":8.22,"value":411.0,"ownership":{"direct":true},"balance_after":50,"source":{"system":"sec-edgar","filing":"0000899243-21-029687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924321029687/doc4.xml","form_type":"4"}},{"id":3050676,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2020-08-20T20:08:46.000Z","date":"2020-08-18","kind":"grant","acquired":true,"shares":132260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in five equal annual installments beginning on August 21, 2021."}],"balance_after":132260,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":132260},"source":{"system":"sec-edgar","filing":"0000899243-20-023135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615993/000089924320023135/doc4.xml","form_type":"4"}},{"id":4285036,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T16:40:43.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options will vest on the later of (i) the 6-month anniversary of the grant date and (ii) the date on which the average closing price of the Company's common stock on NASDAQ is at least $3.33 for 30 consecutive trading days, provided that the grantee remains employed by the Company on the vesting date.   25% of the options will vest on the later of (i) the 12-month anniversary of the grant date and (ii) the date on which the average closing price of the Company's common stock on NASDAQ is at least $4.05 for 30 consecutive trading days, provided that the grantee remains employed by the Company on the vesting date.   The remaining 50% of the options will vest on the later of (i) the 24-month anniversary of the grant date and (ii) the date on which the average closing price of the Company's common stock on NASDAQ is at least $4.76 for 30 consecutive trading days, provided that the grantee remains employed by the Company on the vesting date."}],"balance_after":80000,"derivative":{"exercise_price":2.38,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001179110-17-008926","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911017008926/edgar.xml","form_type":"4"}},{"id":4359862,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-04-04T17:05:58.000Z","date":"2017-03-31","kind":"sale","acquired":false,"shares":536,"price":5.16,"value":2765.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale effected pursuant to a Rule 10b5-1 trading plan to pay tax liability on vesting restricted stock. The restricted stock was originally granted on August 6, 2014."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.11 to $5.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18212,"source":{"system":"sec-edgar","filing":"0001179110-17-005586","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911017005586/edgar.xml","form_type":"4"}},{"id":4501459,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-01-04T16:59:20.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":536,"price":7.75,"value":4154.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale effected pursuant to a Rule 10b5-1 trading plan to pay tax liability on vesting restricted stock. The restricted stock was originally granted on August 6, 2014."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18748,"source":{"system":"sec-edgar","filing":"0001179110-17-000257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911017000257/edgar.xml","form_type":"4"}},{"id":4528321,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-08T16:28:42.000Z","date":"2016-12-06","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests with respect to one-fourth of the underlying shares on the first anniversary of the grant date and with respect to one-forty eighth of the underlying shares each month thereafter until fully vested."}],"balance_after":80000,"derivative":{"exercise_price":8.11,"expiration_date":"2026-12-06","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001179110-16-032593","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911016032593/edgar.xml","form_type":"4"}},{"id":4589821,"issuer":{"id":148990,"kind":"organization","name":"Zyla Life Sciences","symbol":"ZCOR"},"owners":[{"id":68780,"kind":"person","name":"Dayno Jeffrey M.","position":1,"cik":"0001615993","reported_name":"Dayno Jeffrey M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-10-03T17:22:00.000Z","date":"2016-09-30","kind":"sale","acquired":false,"shares":536,"price":7.69,"value":4121.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale effected pursuant to a Rule 10b5-1 trading plan to pay tax liability on vesting restricted stock. The restricted stock was originally granted on August 6, 2014."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.65 to $7.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":19284,"source":{"system":"sec-edgar","filing":"0001179110-16-030194","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586105/000117911016030194/edgar.xml","form_type":"4"}}]}